REG - Oncimmune Hldngs PLC - PDMR / PCA Dealings
RNS Number : 0155GOncimmune Holdings PLC12 March 2020Oncimmune Holdings plc
("Oncimmune" or the "Company")
PDMR / PCA Dealings
Oncimmune Holdings plc (AIM: ONC.L), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, has been notified that Geoffrey Hamilton-Fairley, PDMR and Non-Executive Vice Chairman, has transferred 1,907,220 ordinary shares of £0.01 each in the Company ("Ordinary Shares") for nil consideration to his wife (and person closely associated with him) Amanda Hamilton-Fairley on 9 March 2020.
The Company has also been notified that Amanda Hamilton-Fairley, sold 25,000 Ordinary Shares at a price of £0.70 per share on 10 March 2020.
Following this transaction, Geoffrey, together with his wife, have a total interest in the Company of 3,213,070 Ordinary Shares, representing approximately 5.08 per cent of the Company's issued Ordinary Share capital.
This announcement, including the notification below, is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Geoffrey Hamilton-Fairley
2
Reason for the notification
a)
Position/status
Non-Executive Vice Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings plc
b)
LEI
213800HCYIWT6YPI1I02
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.01 each
Identification code
ISIN: GB00BYQ94H38
b)
Nature of the transaction
Transfer of shares
c)
Price(s) and volume(s)
Price
Volume
Nil
1,907,220
d)
Aggregated information
- Aggregated volume
Same as above
- Price
e)
Date of the transaction
9 March 2020
f)
Place of the transaction
London stock exchange, AIM
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Amanda Hamilton-Fairley
2
Reason for the notification
a)
Position/status
Wife / PCA of Non-Executive Vice Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings plc
b)
LEI
213800HCYIWT6YPI1I02
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.01 each
Identification code
ISIN: GB00BYQ94H38
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
Price
Volume
0.70 GBP
25,000
d)
Aggregated information
- Aggregated volume
Same as above
- Price
e)
Date of the transaction
10 March 2020
f)
Place of the transaction
London stock exchange, AIM
For further information:
Oncimmune Holdings plc
Andrew Stewart, General Counsel and Company Secretary
contact@oncimmune.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHEAPDAFDEEEFA
Recent news on Oncimmune Holdings
See all newsREG - Oncimmune Hldgs PLC - Appointment of Nominated Adviser and Joint Broker
AnnouncementREG - Oncimmune Hldgs PLC - Holding(s) in Company
AnnouncementREG - Oncimmune Hldgs PLC - Result of General Meeting
AnnouncementREG - Oncimmune Hldgs PLC - Total Voting Rights
AnnouncementREG - Oncimmune Hldgs PLC - Holding(s) in Company
Announcement